National Research Corporation
NRC
$10.54
$0.010.10%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -2.88% | -5.60% | -3.15% | -3.18% | -0.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.88% | -5.60% | -3.15% | -3.18% | -0.37% |
| Cost of Revenue | 4.04% | 4.59% | 0.85% | -2.97% | -1.39% |
| Gross Profit | -6.82% | -12.00% | -5.48% | -3.32% | 0.21% |
| SG&A Expenses | 3.28% | -6.72% | -6.23% | -4.52% | 5.02% |
| Depreciation & Amortization | 6.01% | -0.58% | -0.53% | 3.80% | 4.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.83% | -0.46% | -2.39% | -3.29% | 1.51% |
| Operating Income | -17.94% | -20.02% | -5.34% | -2.84% | -4.35% |
| Income Before Tax | -22.61% | -27.32% | -11.86% | -9.07% | 21.07% |
| Income Tax Expenses | -11.30% | -25.66% | -1.01% | -10.36% | -7.81% |
| Earnings from Continuing Operations | -25.94% | -27.78% | -15.10% | -8.69% | 33.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.94% | -27.78% | -15.10% | -8.69% | 33.38% |
| EBIT | -17.94% | -20.02% | -5.34% | -2.84% | -4.35% |
| EBITDA | -15.34% | -17.39% | -4.67% | -1.95% | -3.51% |
| EPS Basic | -22.49% | -25.20% | -12.58% | -5.90% | 34.57% |
| Normalized Basic EPS | -18.85% | -24.91% | -9.28% | -6.33% | 22.11% |
| EPS Diluted | -22.15% | -25.06% | -10.83% | -4.86% | 33.84% |
| Normalized Diluted EPS | -18.53% | -24.58% | -8.92% | -6.15% | 22.18% |
| Average Basic Shares Outstanding | -4.43% | -3.42% | -2.88% | -2.92% | -0.86% |
| Average Diluted Shares Outstanding | -4.82% | -3.85% | -3.24% | -3.13% | -0.92% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.29% | -0.86% | 0.14% | 0.08% | -0.63% |